[Activity Report] The 7th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (November 7, 2020)
date : 12/1/2020
Tags: AMR
The AMR Consortium (Secretariat: AMR Alliance Japan) of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) shared key points of its policy recommendations calling for the creation of a pull incentive to encourage antimicrobial R&D at the 7th NIKKEI FT Communicable Diseases Conference.
Over the past year, the AMR Consortium has debated schemes that would be able to incentivize antimicrobial R&D in the future.
At the NIKKEI FT Communicable Diseases Conference, the Consortium shared key points from policy recommendations that were developed based on that debate, and considered points to be discussed further in the future.
In light of the situation with novel coronavirus, this conference was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Saturday, November 11, 2020
Program: Agenda4- Performance of PPP from the Conference and Future Issues
■Discussion
Participants from AMR Consortium of the Nikkei Asia Africa Conference on Communicable Diseases –Asia Africa Medical Innovation Consortium (AMIC) (alphabetical order by last name) :
Hajime Inoue (Deputy Director General, Office for Novel Coronavirus Disease Control, Cabinet Secretariat)
Shoji Miyagawa (Director, Division of Basic Medical Research, Department of Basic Medical Research, the Japan Agency for Medical Research and Development)
Takeo Morooka (Executive Officer, Head of Health Policy and Corporate Support, MSD K.K.)
Hiroyuki Noda (Councilor, Coordination Office of Measures on Emerging Infectious Diseases, Office of Pandemic Influenza and New Infectious Diseases Preparedness and Response, Cabinet Secretariat)
Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
Jean-Pierre Paccaud(Director of Business Development and Corporate Strategy, Global Antibiotic R&D Partnership Foundation (GARDP))
Takuko Sawada (Director of the Board, Executive Vice President, Shionogi & Co., Ltd.)
Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases/President, The Japanese Society for Clinical Microbiology/Professor, Department of Microbiology and Infectious Diseases, Toho University)
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
Yasuhide Yamada (Former Director-General of Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat, Government of Japan Executive Officer/Executive Officer, SHIMIZU CORPORATION)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 23, 2020 The Third Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
Top Research & Recommendations Posts
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-10-07
[Registration Open] International Dialogue “Fostering Community and Citizen-led Approaches to AMR: Lessons from Antibiotic Smart Sweden” (October 25, 2024)
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Open] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-09
[Registration Open] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)